IFRS 15 · Belgium

IFRS 15 Revenue Flowchart — Belgium Edition

Navigate the five-step revenue model under EU-endorsed IFRS 15, with guidance aligned to FSMA expectations and Belgian holding company considerations.

Step 1: Identify the Contract

IFRS 15.9–21All five criteria must be met for a contract to exist
a
Have the parties approved the contract and are committed to perform their respective obligations?
IFRS 15.9(a)
Approval can be written, oral, or implied by customary business practice. Commitment means the parties intend to enforce their respective rights. Consider whether there is a signed agreement, purchase order, or established pattern of dealing that evidences approval.
b
Can the entity identify each party's rights regarding the goods or services to be transferred?
IFRS 15.9(b)
The contract must establish enforceable rights for each party. This includes identifying what goods or services the entity will transfer and what the customer is entitled to receive. Even if terms are implicit or established by customary business practice, rights must be identifiable.
c
Can the entity identify the payment terms for the goods or services to be transferred?
IFRS 15.9(c)
Payment terms include the amount, timing, and form of consideration. The terms need not be explicitly stated if they can be determined from customary business practices or the contract's terms and conditions. Consider fixed prices, variable elements, milestone payments, and credit terms.
d
Does the contract have commercial substance — that is, the risk, timing, or amount of the entity's future cash flows is expected to change as a result of the contract?
IFRS 15.9(d)
A contract has commercial substance when it is expected to change the entity's future cash flows. This criterion prevents entities from recognising revenue on reciprocal exchanges of goods or services of similar nature and value (e.g., barter transactions between oil companies to fulfil demand in different locations). Most arm's-length commercial transactions have commercial substance.
e
Is it probable that the entity will collect the consideration to which it is entitled in exchange for the goods or services that will be transferred to the customer?
IFRS 15.9(e)
Assess the customer's ability and intention to pay. Consider the customer's credit history, financial condition, collateral or guarantees, and the entity's past experience with similar classes of customers. 'Probable' means more likely than not under IFRS. If the entity offers a price concession, assess collectability on the reduced (expected) amount, not the stated contract price (IFRS 15.9.A1).

Contract Combination Assessment

(Optional)
Are there multiple contracts with the same customer (or related parties) entered at or near the same time that should be combined?

Contract Modification Assessment

(Optional)
Local standard: EU-endorsed IFRS 15
Regulator: Financial Services and Markets Authority (FSMA)

IFRS 15 in Belgium

IFRS 15 Adoption in Belgium

Belgium adopted IFRS 15 Revenue from Contracts with Customers through the EU endorsement mechanism, effective for annual periods beginning on or after 1 January 2018. Belgian entities listed on Euronext Brussels and other regulated markets must prepare their consolidated financial statements under EU-endorsed IFRS, including IFRS 15 without modifications. The Financial Services and Markets Authority (FSMA) supervises the quality of financial reporting by listed entities. Non-listed Belgian entities prepare their individual and consolidated financial statements under Belgian GAAP, which is governed by the Code des Sociétés et des Associations (CSA) / Wetboek van Vennootschappen en Verenigingen (WVV) and the accounting standards issued by the Commission des Normes Comptables (CNC) / Commissie voor Boekhoudkundige Normen (CBN). Belgian GAAP revenue recognition follows the prudence principle and the risks-and-rewards transfer model, differing significantly from the IFRS 15 five-step control-transfer approach.

FSMA Supervisory Expectations

The FSMA reviews the financial reporting of Belgian listed entities and has identified revenue recognition as an area requiring ongoing scrutiny. Key FSMA observations include the need for entity-specific IFRS 15 policy disclosures that explain how the five-step model applies to the entity's particular revenue streams, adequate disclosure of significant judgements affecting the identification of performance obligations and the timing of revenue recognition, and clear presentation of the impact of IFRS 15 on key financial metrics and alternative performance measures. The FSMA has aligned its supervisory approach with the common enforcement priorities published annually by the European Securities and Markets Authority (ESMA), which regularly include IFRS 15-related focus areas. Belgian entities should review both the FSMA communications and the ESMA enforcement priority statements when preparing their IFRS 15 disclosures.

Belgian GAAP Alternative: CBN/CNC Standards

Belgian GAAP, as regulated by CBN/CNC advisories, retains a traditional revenue recognition framework that is distinct from IFRS 15. Revenue is recognised when the risks and rewards of ownership transfer to the buyer, generally at the point of delivery for goods and completion or proportional performance for services. The CBN/CNC has issued advisories on specific revenue recognition topics, including the treatment of construction contracts and long-term service arrangements, but has not converged Belgian GAAP with IFRS 15. The CSA/WVV prescribes the chart of accounts (minimum algemeen rekeningenstelsel / plan comptable minimum normalisé) used by Belgian entities, which includes specific revenue categories that must be reported in the statutory accounts. Belgian entities preparing both IFRS consolidated statements and Belgian GAAP statutory accounts must reconcile differences in revenue recognition timing and measurement between the two frameworks.

ICCI Guidance and Audit Quality

The Instituut van de Bedrijfsrevisoren (IBR) / Institut des Réviseurs d'Entreprises (IRE), now operating under the governance framework of the College van Toezicht op de Bedrijfsrevisoren (CTR) / Collège de supervision des réviseurs d'entreprises (CSR), has issued guidance relevant to the audit of IFRS 15. The Institut des Censeurs de Comptes Internes (ICCI) provides practical guidance for Belgian auditors (bedrijfsrevisoren / réviseurs d'entreprises) on the application of ISAs in the Belgian context. Key audit focus areas for IFRS 15 include the identification and testing of performance obligations in complex contracts, the evaluation of management's standalone selling price estimates and transaction price allocations, and the assessment of whether over-time or point-in-time recognition has been appropriately applied. Belgian audit quality inspections conducted by the CTR/CSR have identified instances where auditors did not sufficiently challenge management's revenue recognition judgements.

Belgian Holding Company Structures

Belgium is a significant jurisdiction for holding company structures due to its participation exemption regime, innovation income deduction, and extensive tax treaty network. Belgian holding companies that hold subsidiaries engaged in diverse operational activities must apply IFRS 15 at the consolidated group level, considering the revenue recognition requirements applicable to each subsidiary's operations. The identification of performance obligations across group companies, the elimination of intercompany revenue, and the assessment of agency versus principal relationships within the group require careful application of the IFRS 15 framework. Management fees and shared service charges between holding companies and operating subsidiaries must be assessed to determine whether they represent contracts with customers within the scope of IFRS 15 or whether they are excluded as intercompany transactions eliminated on consolidation.

Industry Considerations: Pharmaceuticals, Logistics, and Chemicals

Belgium's economy includes significant concentrations in pharmaceuticals and biotechnology, logistics and distribution, chemicals, and food processing. Pharmaceutical companies face complex IFRS 15 issues including the treatment of licensing arrangements with milestone payments, the allocation of the transaction price to intellectual property licences and manufacturing services, and the assessment of whether licences represent rights to access or rights to use under IFRS 15 paragraphs B56-B63. The Port of Antwerp-Bruges, one of Europe's largest ports, anchors a substantial logistics and distribution sector where revenue from port services, warehousing, and freight forwarding requires analysis of distinct performance obligations and the principal-versus-agent determination. Chemical companies must address revenue recognition for tolling arrangements, contract manufacturing, and buy-sell arrangements where the determination of whether the entity is principal or agent significantly affects reported revenue.

Regulatory Inspection Focus Areas

FSMA reviews have identified generic IFRS 15 policy disclosures that do not explain the application of the five-step model to specific contracts, insufficient disclosure of significant judgements on performance obligation identification, and inadequate revenue disaggregation. CTR/CSR audit inspections found that auditors did not sufficiently challenge management's variable consideration estimates and did not adequately test standalone selling price allocations in bundled arrangements.

IFRS 15 Revenue Recognition Audit Toolkit — free PDF

Complete audit toolkit: IFRS 15 five-step decision flowchart poster, contract assessment template, PO identification checklist, and SSP allocation worksheet.

No spam. Unsubscribe anytime.

Frequently Asked Questions

Does Belgian GAAP follow IFRS 15 for revenue recognition?
No. Belgian GAAP, governed by CBN/CNC advisories and the CSA/WVV, retains the traditional risks-and-rewards transfer model for revenue recognition. IFRS 15 applies only to Belgian entities preparing IFRS consolidated financial statements, primarily listed companies on Euronext Brussels. Non-listed entities reporting under Belgian GAAP continue to recognise revenue based on the transfer of risks and rewards of ownership, without applying the five-step model.
What FSMA expectations apply to IFRS 15 disclosures in Belgium?
The FSMA expects entity-specific revenue recognition policy descriptions, disclosure of significant judgements in identifying performance obligations and determining transaction prices, meaningful disaggregation of revenue, and clear explanation of variable consideration and constraint assessments. The FSMA aligns with ESMA common enforcement priorities and may challenge entities whose disclosures are generic or do not adequately explain the application of the five-step model to specific contracts.
How do Belgian holding company structures affect IFRS 15 application?
Belgian holding companies must apply IFRS 15 at the consolidated level for all group revenue streams. This requires understanding each subsidiary's contracts and revenue recognition policies, ensuring consistent application of the five-step model across the group, properly eliminating intercompany revenue, and assessing whether management fees and shared service charges represent contracts with customers. The holding company must also determine the correct principal-versus-agent classification for group companies that sell through intermediary subsidiaries.
What ICCI guidance exists for auditing IFRS 15 in Belgium?
The ICCI provides guidance on applying ISAs to Belgian audits, including the treatment of revenue recognition as a presumed fraud risk under ISA 240. Belgian auditors should perform substantive procedures addressing the identification of performance obligations, the allocation of the transaction price, and the timing of recognition. The CTR/CSR has highlighted weaknesses in auditor challenge of management's judgements and expects auditors to involve specialists where revenue contracts are complex.
How should Belgian pharmaceutical companies apply IFRS 15 to licence arrangements?
Pharmaceutical companies must determine whether a licence of intellectual property provides the customer with a right to access the IP (revenue recognised over time) or a right to use the IP (revenue recognised at a point in time) under IFRS 15 paragraphs B56-B63. Milestone payments must be assessed as variable consideration subject to the constraint in IFRS 15.56-58. The entity must evaluate whether development and commercialisation services are distinct from the licence and, if so, allocate the transaction price based on relative standalone selling prices.